14.46
price up icon0.00%   0.00
after-market 시간 외 거래: 14.46
loading
전일 마감가:
$14.46
열려 있는:
$14.45
하루 거래량:
4.93M
Relative Volume:
0.98
시가총액:
$4.54B
수익:
$634.21M
순이익/손실:
$-27.11M
주가수익비율:
-163.39
EPS:
-0.0885
순현금흐름:
$29.85M
1주 성능:
+0.00%
1개월 성능:
+0.63%
6개월 성능:
+72.76%
1년 성능:
+109.57%
1일 변동 폭
Value
$14.45
$14.46
1주일 범위
Value
$14.45
$14.47
52주 변동 폭
Value
$5.51
$14.48

아미쿠스 테라 Stock (FOLD) Company Profile

Name
명칭
Amicus Therapeutics Inc
Name
전화
(609) 662-2000
Name
주소
47 HULFISH STREET, PRINCETON, NJ
Name
직원
511
Name
트위터
@amicusrx1
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
FOLD's Discussions on Twitter

Compare FOLD vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
FOLD icon
FOLD
Amicus Therapeutics Inc
14.46 4.54B 634.21M -27.11M 29.85M -0.0885
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

아미쿠스 테라 Stock (FOLD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-01-22 다운그레이드 Jefferies Buy → Hold
2025-12-29 다운그레이드 Leerink Partners Outperform → Market Perform
2025-12-22 다운그레이드 TD Cowen Buy → Hold
2025-12-17 개시 Citigroup Buy
2025-09-18 업그레이드 Needham Hold → Buy
2025-07-17 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-12-13 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2024-09-06 개시 Jefferies Buy
2024-05-30 개시 Wells Fargo Overweight
2024-05-14 업그레이드 Guggenheim Neutral → Buy
2023-12-19 업그레이드 Morgan Stanley Equal-Weight → Overweight
2022-09-09 개시 Morgan Stanley Equal-Weight
2022-04-13 재개 Goldman Neutral
2022-01-14 업그레이드 SVB Leerink Mkt Perform → Outperform
2021-11-15 업그레이드 Stifel Hold → Buy
2021-09-30 업그레이드 JP Morgan Neutral → Overweight
2021-07-19 재개 BTIG Research Buy
2021-05-27 개시 Needham Hold
2021-05-21 개시 UBS Buy
2021-04-14 업그레이드 Cantor Fitzgerald Neutral → Overweight
2021-03-02 개시 Stifel Hold
2021-02-12 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2021-02-12 다운그레이드 JP Morgan Overweight → Neutral
2020-12-28 재개 Cantor Fitzgerald Overweight
2020-12-10 다운그레이드 Citigroup Buy → Neutral
2020-11-11 개시 Berenberg Hold
2020-06-17 개시 BTIG Research Buy
2020-02-04 재개 Cantor Fitzgerald Overweight
2019-11-12 재확인 H.C. Wainwright Buy
2019-06-17 개시 H.C. Wainwright Buy
2019-06-05 재확인 Cantor Fitzgerald Overweight
2019-04-05 개시 Janney Buy
2019-01-30 개시 Cantor Fitzgerald Overweight
2018-10-29 개시 Citigroup Neutral
2018-08-17 다운그레이드 Chardan Capital Markets Buy → Neutral
2017-10-06 재개 Goldman Neutral
2017-09-13 재확인 Chardan Capital Markets Buy
2017-08-10 재확인 Chardan Capital Markets Buy
2017-01-24 업그레이드 Robert W. Baird Neutral → Outperform
2016-05-18 개시 BofA/Merrill Buy
2016-04-14 개시 Robert W. Baird Neutral
2016-04-12 재확인 Chardan Capital Markets Buy
2015-09-16 다운그레이드 Chardan Capital Markets Buy → Neutral
2015-06-16 재확인 Chardan Capital Markets Buy
모두보기

아미쿠스 테라 주식(FOLD)의 최신 뉴스

pulisher
Apr 13, 2026

Institution Moves: Can Amicus Therapeutics Inc expand its profit marginsEarnings Overview Summary & Capital Efficient Trading Techniques - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 12, 2026

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates - ADVFN

Apr 12, 2026
pulisher
Apr 11, 2026

Amicus Therapeutics Hits New 52-Week High of $14.47 - Markets Mojo

Apr 11, 2026
pulisher
Apr 11, 2026

How does Amicus Therapeutics Inc score in quality rankings2026 Biggest Moves & Community Shared Stock Ideas - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 10, 2026

Patterns Watch: Will Amicus Therapeutics Inc benefit from geopolitical trendsPortfolio Gains Summary & Consistent Growth Equity Picks - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Apr 10, 2026
pulisher
Apr 09, 2026

(FOLD) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Apr 09, 2026
pulisher
Apr 09, 2026

Amicus Therapeutics Hits New 52-Week High of $14.48 - Markets Mojo

Apr 09, 2026
pulisher
Apr 08, 2026

Panic Selling: Is Amicus Therapeutics Inc showing insider buyingWeekly Market Outlook & Daily Technical Forecast Reports - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

Gap Down: Will Amicus Therapeutics Inc benefit from geopolitical trendsBuy Signal & Reliable Momentum Entry Alerts - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

Will Amicus Therapeutics Inc benefit from geopolitical trends2026 Dividend Review & Fast Gain Stock Trading Tips - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

Amicus Therapeutics stock hits 52-week high at 14.46 USD By Investing.com - Investing.com Australia

Apr 08, 2026
pulisher
Apr 07, 2026

Amicus Therapeutics stock hits 52-week high at 14.46 USD - Investing.com

Apr 07, 2026
pulisher
Apr 07, 2026

FOLD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 07, 2026
pulisher
Apr 07, 2026

Amicus Therapeutics (NASDAQ:FOLD) Hits New 1-Year HighTime to Buy? - MarketBeat

Apr 07, 2026
pulisher
Apr 07, 2026

BioMarin Pharmaceutical Secures European Regulatory Approval for Amicus Therapeutics Acquisition - marketscreener.com

Apr 07, 2026
pulisher
Apr 07, 2026

EU Commission OKs BioMarin's Sole Acquisition of Amicus Therapeutics - marketscreener.com

Apr 07, 2026
pulisher
Apr 06, 2026

Capricorn Fund Managers Ltd Invests $3 Million in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Apr 06, 2026
pulisher
Apr 04, 2026

FOLD Technical Analysis & Stock Price Forecast - intellectia.ai

Apr 04, 2026
pulisher
Apr 01, 2026

Amicus Therapeutics stock hits 52-week high at $14.44 By Investing.com - Investing.com South Africa

Apr 01, 2026
pulisher
Mar 31, 2026

Amicus Therapeutics stock hits 52-week high at $14.44 - Investing.com

Mar 31, 2026
pulisher
Mar 30, 2026

EPS Watch: Is Amicus Therapeutics Inc in a bullish channelMarket Sentiment Report & Weekly High Return Stock Opportunities - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Amicus Therapeutics (NASDAQ:FOLD) Reaches New 1-Year HighStill a Buy? - MarketBeat

Mar 30, 2026
pulisher
Mar 29, 2026

Assessing Amicus Therapeutics (FOLD) Valuation After A Strong 71% One Year Total Return - Yahoo Finance

Mar 29, 2026
pulisher
Mar 29, 2026

210,800 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by CIBRA Capital Ltd - MarketBeat

Mar 29, 2026
pulisher
Mar 29, 2026

FOLD PE Ratio & Valuation, Is FOLD Overvalued - intellectia.ai

Mar 29, 2026
pulisher
Mar 26, 2026

Recap Report: What is the long term forecast for Amicus Therapeutics Inc stockQuarterly Market Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

Vanguard disaggregates holdings, reports 0% in Amicus (NASDAQ: FOLD) - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

JPMorgan Chase & Co. Sells 94,105 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 26, 2026
pulisher
Mar 25, 2026

ETFs investiert in Amicus Therapeutics, Inc.-Aktien - TradingView

Mar 25, 2026
pulisher
Mar 25, 2026

Morgan Stanley Upgrades Amicus (FOLD) on IP Strength and Pipeline Expansion - MSN

Mar 25, 2026
pulisher
Mar 23, 2026

Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week HighWhat's Next? - MarketBeat

Mar 23, 2026
pulisher
Mar 21, 2026

Amicus Therapeutics stock hits 52-week high at 14.39 USD By Investing.com - Investing.com Canada

Mar 21, 2026
pulisher
Mar 20, 2026

Amicus Therapeutics stock hits 52-week high at 14.39 USD - Investing.com

Mar 20, 2026
pulisher
Mar 20, 2026

Hudson Bay Capital Management LP Cuts Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 20, 2026
pulisher
Mar 19, 2026

Amicus Therapeutics, Inc.(NasdaqGM: FOLD) dropped from NASDAQ Biotechnology Index - marketscreener.com

Mar 19, 2026
pulisher
Mar 17, 2026

FOLD Should I Buy - Intellectia AI

Mar 17, 2026
pulisher
Mar 16, 2026

872,411 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by Ion Asset Management Ltd. - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Iron Triangle Partners LP Takes Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

BioMarin to acquire rare disease drug developer Amicus for $4.8B - MSN

Mar 16, 2026
pulisher
Mar 16, 2026

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Mar 16, 2026
pulisher
Mar 15, 2026

Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum And DCF Upside - Yahoo Finance

Mar 15, 2026
pulisher
Mar 15, 2026

Amicus Therapeutics stock hits 52-week high at 14.38 USD By Investing.com - Investing.com Nigeria

Mar 15, 2026
pulisher
Mar 15, 2026

Elevation Point Wealth Partners LLC Makes New Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

Assessing Amicus Therapeutics (FOLD) Valuation After Strong Recent Share Price Momentum - simplywall.st

Mar 15, 2026
pulisher
Mar 14, 2026

Amicus Therapeutics, Inc. $FOLD Shares Sold by Prosight Management LP - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Avoro Capital Advisors LLC Decreases Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat

Mar 14, 2026
pulisher
Mar 12, 2026

Assessing Amicus Therapeutics (FOLD) After Strong One Year Share Price Performance - simplywall.st

Mar 12, 2026
pulisher
Mar 12, 2026

Amicus Therapeutics stock hits 52-week high at 14.38 USD - Investing.com India

Mar 12, 2026

아미쿠스 테라 (FOLD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
자본화:     |  볼륨(24시간):